Aimmune’s Peanut Allergy Drug Wins Broad FDA Panel Backing

(Bloomberg) -- An advisory panel to the U.S. Food and Drug Administration voted in favor of Aimmune Therapeutics Inc.’s Palforzia to treat kids with peanut allergies.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.